A panel of federal health experts has ruled that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies.
Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.